News|Articles|November 18, 2026

Low CRC Incidence Found After Endoscopic Mucosal Resection

Fact checked by: Ashley Gallagher, MA
Listen
0:00 / 0:00

Key Takeaways

  • Incident CRC after EMR was low but measurable at 2.16 per 1000 person-years (22 events/10,187.8 person-years) following a 1-year washout to reduce synchronous cancers.
  • Sensitivity analysis restricted to ages 50-75 produced a nearly identical CRC incidence estimate, supporting robustness across typical screening-age populations.
SHOW MORE

CRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.

A total of 22 colorectal cancer (CRC) diagnoses occurred over more than 10,000 person-years after endoscopic mucosal resection (EMR), according to a study recently published in the Journal of Gastrointestinal Cancer, though too few events occurred to reliably compare incidence by race and ethnicity.1

Real-World CRC Risk as a Factor in Post-EMR Surveillance

EMR has become an established, colon-preserving alternative to surgery for large, flat, or laterally spreading colorectal lesions that cannot be removed with standard polypectomy. However, outcomes vary according to lesion size, morphology, resection technique, completeness of excision, and follow-up. A prior meta-analysis found local recurrence in approximately 15% of nonpedunculated lesions after EMR.2

Although local adenoma recurrence after EMR has been described in procedural cohorts, less is known about the incidence of subsequent CRC diagnoses in real-world populations across health systems, the investigators noted.1 They added that this knowledge gap is particularly important because surveillance after complex polyp resection may be hindered by barriers such as travel distance, language, and insurance continuity.

To examine this, the researchers used the TriNetX US Collaborative Network, which includes 66 health care organizations, to identify patients aged 40 years or older who underwent colonoscopy or sigmoidoscopy with EMR between January 1, 2016, and January 1, 2017. Following a 1-year washout period to limit the capture of synchronous or procedure-related cancers, they assessed incident CRC diagnoses from January 1, 2018, through December 31, 2021.

Patients Face Low but Measurable CRC Risk After EMR

The cohort included 3081 patients with a mean (SD) age of 62.9 (8.89) years; 52% were female, and 76% were White. Of the population, 2735 patients were at risk at the start of follow-up. Over 10,187.8 person-years, 22 patients were diagnosed with CRC, for an incidence of 2.16 per 1000 person-years (95% CI, 1.35-3.27). A sensitivity analysis limited to patients aged 50 to 75 years produced a nearly identical estimate (2.14 per 1000 person-years; 95% CI, 1.29-3.34). Because each calendar year contained 10 or fewer events, annual rates could not be estimated.

CRC incidence was 2.54 per 1000 person-years (95% CI, 1.31-4.44) in men and 1.83 (95% CI, 0.88-3.36) in women. White patients had an incidence of 1.94 per 1000 person-years (95% CI, 1.09-3.20), whereas Black, Asian, and unknown-race patients combined had a higher point estimate of 3.16 per 1000 person-years (95% CI, 1.27-6.52).

However, that comparison was based on only 7 events across the combined groups, with counts for individual racial cohorts masked for privacy. In addition, CIs overlapped across all sex, race, and ethnicity groups.

During years 1 to 5 after the index procedure, 3.9% (n = 119) of patients underwent repeat EMR, 0.9% (n = 28) underwent colorectal surgery, and 42.9% (n = 1321) received a subsequent colorectal polyp diagnosis. The authors noted that the high polyp rate suggested ongoing surveillance, although the codes could not distinguish residual, recurrent, or new lesions. They added that no endoscopic submucosal dissection procedures were identified.

Data Gaps Limit Conclusions on Equitable Surveillance

The researchers acknowledged several limitations. For example, the analysis relied on diagnosis and procedure codes, which are subject to miscoding and undercoding. In addition, surveillance adherence, insurance continuity, and socioeconomic factors were unavailable. Lastly, incidence may be underestimated because cancers diagnosed outside participating health systems would be missed.

At the same time, they explained that the study used a large multicenter electronic health record (EHR) network, included an age-restricted sensitivity analysis, and transparently reported event counts, person-time, and CIs.

“Future studies linking EHR data to endoscopy reports, pathology, lesion location, resection technique, margin treatment, surveillance completion, and care outside the index health system are needed to identify preventable CRC mechanisms after EMR and to guide equitable surveillance strategies,” the authors concluded.

References

  1. Eldesouki MH, Elfert K, Ibrahim EA, Youssef MY, Shaukat A, Thakkar S. Incidence of colorectal cancer after endoscopic mucosal resection: a multicenter electronic health record cohort study. J Gastrointest Cancer. 2026;57:256. doi:10.1007/s12029-026-01634-4
  2. Belderbos TD, Leenders M, Moons LM, Siersema PD. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis. Endoscopy. 2014;46(5):388-402. doi:10.1055/s-0034-1364970


Related to this article